+10.3%return · 30D
$1,000 follows their calls into $1,103
VT $1,004
Sep 16Oct 15
- Win rate
- 59%
- Streak
- 10closes
- Best call
- Long ASMLSame rank since the call
Track record building
- Peak #18
- 10 ranked closes
- Longest streak 10
Polvans@PolvahThe crowd is chasing $MRNA at +600% YTD, best name in the S&P 500 I'm looking at the other side. The company is still guided to lose ~$8 a share this year on ~$2B in revenue. The stock already trades above the average analyst target. 23 analysts rate it a Hold When a stock
